author-photo

Aileen Ryan

Ludwig Institute for Cancer Research

25

Papers

111

Citations

Citation Trend

Filter By

Papers (19) Sort By

Journal Conference Others

A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma.

2021 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (2)
337 Intratumoral immune therapy for recurrent breast cancer with polyICLC, and tremelimumab combined with systemic durvalumab

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A phase I/II study of chemo-immunotherapy with durvalumab (durva) and pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer (PROC): Genomic sequencing and updated efficacy results

2020
Show All
- Source
- Cite
- Save
Citations (2)
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (11)
Abstract B209: Phase 1/2 study of mRNA vaccine therapy + durvalumab (durva) ± tremelimumab (treme) in patients with metastatic non-small cell lung cancer (NSCLC)

2019 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (3)
Abstract A006: Phase 1 study to evaluate the safety and tolerability of MEDI4736 (durvalumab, durva) + tremelimumab (treme) in patients with advanced solid tumors

2019 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) + radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (17)
Abstract A022: Phase 1/2 study to evaluate systemic durvalumab (durva) + intraperitoneal ONCOS-102 in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC)

2019 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
A Phase 1 Clinical Trial of Ipilimumab, Nivolumab and Radiation Therapy for Patients with Metastatic Melanoma

2018 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1/2 study of mRNA vaccine therapy + durvalumab (durva) ± tremelimumab (treme) in patients with metastatic non-small cell lung cancer (NSCLC).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)